APM Aptorum Group Ltd Class A

USD 1.68 0.00 0
Icon

Aptorum Group Ltd Class A (APM) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.68

0.00 (0.00)%

USD 8.71M

796.00

N/A

N/A

Icon

APM

Aptorum Group Ltd Class A (USD)
COMMON STOCK | NSD
USD 1.68
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 8.71M

N/A

USD 1.68

Aptorum Group Ltd Class A (APM) Stock Forecast

N/A

Based on the Aptorum Group Ltd Class A stock forecast from 0 analysts, the average analyst target price for Aptorum Group Ltd Class A is not available over the next 12 months. Aptorum Group Ltd Class A’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Aptorum Group Ltd Class A is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Aptorum Group Ltd Class A’s stock price was USD 1.68. Aptorum Group Ltd Class A’s stock price has changed by -10.16% over the past week, -0.60% over the past month and -53.33% over the last year.

No recent analyst target price found for Aptorum Group Ltd Class A
No recent average analyst rating found for Aptorum Group Ltd Class A

Company Overview Aptorum Group Ltd Class A

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline produ...Read More

https://adpeppergroup.com

Frankenstrasse 150 C, Nuremberg, Germany, 90461

18

December

USD

USA

Adjusted Closing Price for Aptorum Group Ltd Class A (APM)

Loading...

Unadjusted Closing Price for Aptorum Group Ltd Class A (APM)

Loading...

Share Trading Volume for Aptorum Group Ltd Class A Shares

Loading...

Compare Performance of Aptorum Group Ltd Class A Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for APM

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Aptorum Group Ltd Class A (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD90.49B 26.38 17.57

ETFs Containing APM

Symbol Name APM's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Aptorum Group Ltd Class A (APM) Stock

Stock Target Advisor's fundamental analysis for Aptorum Group Ltd Class A's stock is Bearish.

Unfortunately we do not have enough data on APM's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on APM's stock to indicate what its average analyst target is.

APM stock's Price/Earning ratio is 12.38. Our analysis grades APM stock's Price / Earning ratio at F. This means that APM stock's Price/Earning ratio is above 61% of the stocks in the Biotechnology sector in the NSD exchange. Based on this APM may be a overvalued for its sector.

The last closing price of APM's stock was USD 1.68.

The most recent market capitalization for APM is USD 8.71M.

Unfortunately we do not have enough analyst data on APM's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Aptorum Group Ltd Class A's stock.

As per our most recent records Aptorum Group Ltd Class A has 18 Employees.

Aptorum Group Ltd Class A's registered address is Frankenstrasse 150 C, Nuremberg, Germany, 90461. You can get more information about it from Aptorum Group Ltd Class A's website at https://adpeppergroup.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...